Information on new approvals and medication safety
Search results for: psoriasis
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Maintenance of Certification Is Not Just for the Young
I certainly am relieved to know that I will never need to recertify with the American Board of Internal Medicine Maintenance of Certification, but this feeling is shadowed by a deep sense of shame. I decided to step up and take advantage of all the wonderful recertification programs the ACR has to offer.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
New Diagnostic Criteria for Axial Spondylarthritis
New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
Drug Updates
Information on new approvals and medication safety
Drug Updates
Information on new approvals and medication safety
Thoughts after a Broken Ankle
A forced convalescence leads to insights into rheumatology and medicine
A Unique Structure for Tackling Psoriatic Disease
GRAPPA brings together a group of highly motivated physicians to address these complex disorders
Drug Updates
Information on New Approvals and Medication Safety
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- 53
- Next Page »